BioMark Diagnostics Inc.
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the detection and quantitation of metabolites. Our global enterprise team of proven scientists, engineers and medical professionals is hand-picked. The company’s goal is to commercialize our innovative technology. And we strive to increase the predictive accuracy in early stage cancer detection. We adhere to and follow the highest regulatory, clinical and scientific standards. Since 2007, our mission and team commitment remains the same. Develop and commercialize innovative technologies. Increase the prediction and accuracy of early stage diagnosis of cancers.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Biomarkers play a critical role in all stages of disease. This is why rigorous evaluation is important. Analytical validation, clinical validation, and assessment of clinical utility. Each is important before the incorporation of routine clinical care. This is an important dimension of BioMark’s daily operational activity.